Study of some immunological parameters in hematological malignancies patients

https://doi.org/10.53730/ijhs.v6nS4.9087

Authors

  • Raghad Ridha Kadhem University of Kerbala, College of Education for Pure Sciences, Iraq
  • Hiyame Abdel Ridha Kareem University of Kerbala, College of Education for Pure Sciences, Iraq
  • Karrar Abd Ali Jahil University of Kerbala, College of Education for Pure Sciences, Iraq

Keywords:

immunological parameters, hematological malignancies, patients

Abstract

This study aimed to verify the number of differentiation aggregates that include HLA-DR, CD5 and CD7 In patients with hematological malignancies and comparing them with the healthy group, where the levels of these subgroups were detected in the peripheral blood of 40 males and females, Where samples were collected by 20 samples from patients with malignant hematomas, Plus 20 people from the healthy group.All blood samples and available data were collected from patients with hematological malignancies, from the Center for Oncology and Hematology,in partnership with the laboratories of medical centers and Al-Jawadeen National Laboratory, for the period from November 2021 to May 2022.The immunophenotypes of HLA-DR, CD5 and CD7 were studied in the samples using the flow cytometry technique,where the rate of differentiation aggregates in patients with leukemia was much higher than in healthy people, where the results showed significant differences with statistical significance at the level of  P≤ 0.05 in the proportion of CD5, CD7 and HLA-DR in samples of patients with hematological malignant diseases, and a slight increase in the level of CD5 and HLA-DR was found in males than in females, and a slight decrease in the level of CD7 was observed in males than in females.

Downloads

Download data is not yet available.

References

Antonopoulos, C. N., Sergentanis, T. N., Papadopoulou, C., Andrie, E., Dessypris, N., Panagopoulou, P., Polychronopoulou, S., Pourtsidis, A., Athanasiadou-Piperopoulou, F., Kalmanti, M., Sidi, V., Moschovi, M., & Petridou, E. T. (2011). Maternal smoking during pregnancy and childhood lymphoma: A meta-analysis. International Journal of Cancer, 129(11). https://doi.org/10.1002/ijc.25929

Arber, D. A., Orazi, A., Hasserjian, R., Thiele, J., Borowitz, M. J., Le Beau, M. M., Bloomfield, C. D., Cazzola, M., & Vardiman, J. W. (2016). The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood, 127(20), 2391–2405. https://doi.org/10.1182/blood-2016-03-643544

Bardet, V., Wagner-Ballon, O., Guy, J., Morvan, C., Debord, C., Trimoreau, F., Benayoun, E., Chapuis, N., Freynet, N., Rossi, C., Mathis, S., Gourin, M. P., Toma, A., Béné, M. C., Feuillard, J., & Guérin, E. (2015). Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Haematologica, 100(4), 472–478. https://doi.org/10.3324/haematol.2014.112755

Benjamin Chun-Kit Tong. (2017). 乳鼠心肌提取 HHS Public Access. Physiology & Behavior, 176(5), 139–148. https://doi.org/10.1002/eji.201545663.CD5

Brown, M. H., & Lacey, E. (2010). Europe PMC Funders Group Europe PMC Funders Author Manuscripts A Ligand for CD5 is CD5. 185(10), 6068–6074. https://doi.org/10.4049/jimmunol.0903823.A

Campoli, M., & Ferrone, S. (2008). HLA antigen changes in malignant cells: Epigenetic mechanisms and biologic significance. Oncogene, 27(45), 5869–5885. https://doi.org/10.1038/onc.2008.273

Cartwright, R. A., Gurney, K. A., & Moorman, A. V. (2002). Sex ratios and the risks of haematological malignancies. British Journal of Haematology, 118(4). https://doi.org/10.1046/j.1365-2141.2002.03750.x

Garner, H., & de Visser, K. E. (2020). Immune crosstalk in cancer progression and metastatic spread: a complex conversation. In Nature Reviews Immunology (Vol. 20, Issue 8). https://doi.org/10.1038/s41577-019-0271-z

Garner, H., & de Visser, K. E. (2020). Immune crosstalk in cancer progression and metastatic spread: a complex conversation. In Nature Reviews Immunology (Vol. 20, Issue 8). https://doi.org/10.1038/s41577-019-0271-z

Giri, M. K. W. (2019). Immunological side in overtraining exercise. International Journal of Health & Medical Sciences, 2(1), 1-6. https://doi.org/10.31295/ijhms.v2n1.52

Jaseb, K., Purrahman, D., Shahrabi, S., Ghanavat, M., Rezaeean, H., & Saki, N. (2019). Prognostic significance of aberrant CD5 expression in B-cell leukemia. Oncology Reviews, 13(1), 77–82. https://doi.org/10.4081/oncol.2019.400

Keskinen, P., Ronni, T., Matikainen, S., Lehtonen, A., & Julkunen, I. (1997). Regulation of HLA class I and II expression by interferons and influenza A virus in human peripheral blood mononuclear cells. Immunology, 91(3), 421–429. https://doi.org/10.1046/j.1365-2567.1997.00258.x

Nkanga, M. S. N., Longo-Mbenza, B., Adeniyi, O. V., Ngwidiwo, J. B., Katawandja, A. L., Kazadi, P. R. B., & Nzonzila, A. N. (2017). Ageing, exposure to pollution, and interactions between climate change and local seasons as oxidant conditions predicting incident hematologic malignancy at KINSHASA university clinics, Democratic Republic of CONGO (DRC). BMC Cancer, 17(1), 1–7. https://doi.org/10.1186/s12885-017-3547-3

Olaniyi. (2011). Flow cytometric immunophenotyping of hematological malignancies: the way forward in Nigeria. Pathology and Laboratory Medicine International, 17. https://doi.org/10.2147/plmi.s20709

Pasqualetti, P., Festuccia, V., Acitelli, P., Collacciani, A., Giusti, A., & Casale, R. (1997). Tobacco smoking and risk of haematological malignancies in adults: A case-control study. British Journal of Haematology, 97(3). https://doi.org/10.1046/j.1365-2141.1997.942910.x

Psaltopoulou, T., Sergentanis, T. N., Ntanasis-Stathopoulos, I., Tzanninis, I. G., Tsilimigras, D. I., & Dimopoulos, M. A. (2018). Alcohol consumption and risk of hematological malignancies: A meta-analysis of prospective studies. International Journal of Cancer, 143(3). https://doi.org/10.1002/ijc.31330

Ramdass, B., Chowdhary, A., & Koka, P. S. (2013). Hematological malignancies: Disease pathophysiology of leukemic stem cells. Journal of Stem Cells, 8(3–4). https://doi.org/jsc.2014.8.3/4.151

Schmidt, A., & Weber, O. F. (2006). In memoriam of Rudolf virchow: a historical retrospective including aspects of inflammation, infection and neoplasia. Contributions to Microbiology, 13. https://doi.org/10.1159/000092961

Schmit, T., Klomp, M., & Khan, M. N. (2021). An Overview of Flow Cytometry: Its Principles and Applications in Allergic Disease Research. In Methods in Molecular Biology (Vol. 2223). https://doi.org/10.1007/978-1-0716-1001-5_13

Seita, J., & Weissman, I. L. (2010). Published in final edited form as: Hematopoietic Stem Cell: Self-renewal versus Differentiation. Wiley Interdiscip Rev.Syst. Biol.Med., 2(5), 1–20. https://doi.org/10.1002/wsbm.86.Hematopoietic

Sempowski, G. D., Lee, D., Kaufman, R. E., & Haynes, B. F. (1999). Structure and function of the CD7 molecule. Critical Reviews in Immunology, 19(4).

Singh, N., Baby, D., Rajguru, J., Patil, P., Thakkannavar, S., & Pujari, V. (2019). Inflammation and cancer. Annals of African Medicine, 18(3). https://doi.org/10.4103/aam.aam_56_18

Slager, S. L., Benavente, Y., Blair, A., Vermeulen, R., Cerhan, J. R., Costantini, A. S., Monnereau, A., Nieters, A., Clavel, J., Call, T. G., Maynadié, M., Lan, Q., Clarke, C. A., Lightfoot, T., Norman, A. D., Sampson, J. N., Casabonne, D., Cocco, P., & de Sanjosé, S. (2014). Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia/small lymphocytic lymphoma: The InterLymph non-Hodgkin lymphoma subtypes project. Journal of the National Cancer Institute - Monographs, 48, 41–51. https://doi.org/10.1093/jncimonographs/lgu001

Smith, A., Howell, D., Patmore, R., Jack, A., & Roman, E. (2011). Incidence of haematological malignancy by sub-type: A report from the Haematological Malignancy Research Network. British Journal of Cancer, 105(11), 1684–1692. https://doi.org/10.1038/bjc.2011.450

Söderberg, K. C., Hagmar, L., Schwartzbaum, J., & Feychting, M. (2004). Allergic conditions and risk of hematological malignancies in adults: A cohort study. BMC Public Health, 4. https://doi.org/10.1186/1471-2458-4-51

Stillwell, R., & Bierer, B. E. (2001). T cell signal transduction and the role of CD7 in costimulation. Immunologic Research, 24(1). https://doi.org/10.1385/IR:24:1:31

Sztankay, M., Giesinger, J., & Holzner, B. (2011). Gender differences in quality of life in patients with haematological malignancies. In Memo - Magazine of European Medical Oncology (Vol. 4, Issue 4). https://doi.org/10.1007/s12254-011-0299-7

Widana, I.K., Dewi, G.A.O.C., Suryasa, W. (2020). Ergonomics approach to improve student concentration on learning process of professional ethics. Journal of Advanced Research in Dynamical and Control Systems, 12(7), 429-445.

Widana, I.K., Sumetri, N.W., Sutapa, I.K., Suryasa, W. (2021). Anthropometric measures for better cardiovascular and musculoskeletal health. Computer Applications in Engineering Education, 29(3), 550–561. https://doi.org/10.1002/cae.22202

Zola, H., Swart, B., Nicholson, I., Aasted, B., Bensussan, A., Boumsell, L., Buckley, C., Clark, G., Drbal, K., Engel, P., Hart, D., Horejsí, V., Isacke, C., Macardle, P., Malavasi, F., Mason, D., Olive, D., Saalmueller, A., Schlossman, S. F., … Warren, H. (2005). CD molecules 2005: Human cell differentiation molecules. Blood, 106(9), 3123–3126. https://doi.org/10.1182/blood-2005-03-1338

Published

16-06-2022

How to Cite

Kadhem, R. R., Kareem, H. A. R., & Jahil, K. A. A. (2022). Study of some immunological parameters in hematological malignancies patients. International Journal of Health Sciences, 6(S4), 4205–4213. https://doi.org/10.53730/ijhs.v6nS4.9087

Issue

Section

Peer Review Articles